Search in:

mAbs Volume 15, 2023 - Issue 1

Submit an article Journal homepage

Open access

7,093

Views

CrossRef citations to date

Altmetric

Review

Strategies for clinical dose optimization of T cell-engaging therapies in oncology

Kathryn Balla Clinical Pharmacology and Quantitative Pharmacology, Biopharmaceuticals R&D, AstraZeneca, Cambridge, UKCorrespondence[email protected]

https://orcid.org/0000-0002-5654-8732 View further author information

Simon J Dovedib Early Oncology R&D, AstraZeneca, Cambridge, UKView further author information

Pavan Vajjaha Clinical Pharmacology and Quantitative Pharmacology, Biopharmaceuticals R&D, AstraZeneca, Cambridge, UKView further author information

Alex Phippsa Clinical Pharmacology and Quantitative Pharmacology, Biopharmaceuticals R&D, AstraZeneca, Cambridge, UKView further author information

Article: 2181016 | Received 07 Nov 2022, Accepted 13 Feb 2023, Published online: 23 Feb 2023

Cite this article
https://doi.org/10.1080/19420862.2023.2181016
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF View EPUB EPUB

Citations (10)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Articles from other publishers (10)

Pooneh Soltantabar, Sheena Sharma, Diane Wang, Hoi‐Kei Lon, Akos Czibere, Anne Hickmann & Mohamed Elmeliegy. (2024) Impact of Treatment Modality and Route of Administration on Cytokine Release Syndrome in Relapsed or Refractory Multiple Myeloma: A Meta‐Analysis. Clinical Pharmacology & Therapeutics 115:6, pages 1258-1268.
Crossref

Adrián Sanvicente García, Manuel Pedregal, Lucía Paniagua-Herranz, Cristina Díaz-Tejeiro, Cristina Nieto-Jiménez, Pedro Pérez Segura, Gyöngyi Munkácsy, Balázs Győrffy, Emiliano Calvo, Víctor Moreno & Alberto Ocaña. (2024) Clinical and Immunologic Characteristics of Colorectal Cancer Tumors Expressing LY6G6D. International Journal of Molecular Sciences 25:10, pages 5345.
Crossref

Milena Blaz Kovac & Bostjan Seruga. (2024) Potentially fatal complications of new systemic anticancer therapies: pearls and pitfalls in their initial management. Radiology and Oncology 0:0.
Crossref

Donna Catamero, Patricia Blázquez Benito, Samantha Shenoy, Margaret Doyle, Jessica Fowler, Rachel Kobos, Arnob Banerjee & Sandy Kruyswijk. (2024) Nursing Considerations for Cytokine Release Syndrome in Relapsed/Refractory Multiple Myeloma: Experience with Teclistamab from the MajesTEC-1 Study. Seminars in Oncology Nursing, pages 151621.
Crossref

John D. Davis, Marçal Bravo Padros, Daniela J. Conrado, Samit Ganguly, Xiaowen Guan, Hazem E. Hassan, Anasuya Hazra, Susan C. Irvin, Priya Jayachandran, Matthew P. Kosloski, Kuan‐Ju Lin, Kamalika Mukherjee, Anne Paccaly, Apostolos Papachristos, Michael A. Partridge, Saileta Prabhu, Jennifer Visich, Erik S. Welf, Xiaoying Xu, An Zhao & Min Zhu. (2024) Subcutaneous Administration of Monoclonal Antibodies: Pharmacology, Delivery, Immunogenicity, and Learnings From Applications to Clinical Development. Clinical Pharmacology & Therapeutics 115:3, pages 422-439.
Crossref

William K. Kelly, Daniel C. Danila, Chia-Chi Lin, Jae-Lyun Lee, Nobuaki Matsubara, Patrick J. Ward, Andrew J. Armstrong, David Pook, Miso Kim, Tanya B. Dorff, Stefanie Fischer, Yung-Chang Lin, Lisa G. Horvath, Christopher Sumey, Zhao Yang, Gabor Jurida, Kristen M. Smith, Jamie N. Connarn, Hweixian L. Penny, Julia Stieglmaier & Leonard J. Appleman. (2024) Xaluritamig, a STEAP1 × CD3 XmAb 2+1 Immune Therapy for Metastatic Castration-Resistant Prostate Cancer: Results from Dose Exploration in a First-in-Human Study. Cancer Discovery 14:1, pages 76-89.
Crossref

Yue Guo, Natalia A. Quijano Cardé, Lijuan Kang, Raluca Verona, Arnob Banerjee, Rachel Kobos, Katherine Chastain, Clarissa Uhlar, Kodandaram Pillarisetti, Margaret Doyle, Jennifer Smit, Nahor Haddish‐Berhane & Daniele Ouellet. (2024) Teclistamab: Mechanism of action, clinical, and translational science. Clinical and Translational Science 17:1.
Crossref

Timothy Qi, Xiaozhi Liao & Yanguang Cao. (2023) Development of bispecific T cell engagers: harnessing quantitative systems pharmacology. Trends in Pharmacological Sciences 44:12, pages 880-890.
Crossref

Mohamed H. Omer, Areez Shafqat, Omar Ahmad, Khaled Alkattan, Ahmed Yaqinuddin & Moussab Damlaj. (2023) Bispecific Antibodies in Hematological Malignancies: A Scoping Review. Cancers 15:18, pages 4550.
Crossref

Atanasio Pandiella, Emiliano Calvo, Victor Moreno, Eitan Amir, Arnoud Templeton & Alberto Ocana. (2023) Considerations for the clinical development of immuno-oncology agents in cancer. Frontiers in Immunology 14.
Crossref

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Strategies for clinical dose optimization of T cell-engaging therapies in oncology

Articles from other publishers (10)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Strategies for clinical dose optimization of T cell-engaging therapies in oncology

Citations (10)

Articles from other publishers (10)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date